期刊文献+

HPLC测定阿齐沙坦片的含量 被引量:2

Determination of Azilsartan Tablets by HPLC
下载PDF
导出
摘要 目的建立高效液相色谱法(HPLC)测定阿齐沙坦片含量的方法。方法采用Welch Ultimate XB C18(150 mm×4.6 mm,5μm)色谱柱,流动相为乙腈-缓冲液(p H 2.8)(取磷酸二氢钠1.56 g和戊烷磺酸钠0.87g,加入1000 ml水使溶解,用磷酸调pH 2.8)(45:55),检测波长251 nm,流速1.0 ml/min。结果阿齐沙坦浓度在0.021~0.5232 mg/ml范围内线性关系良好(r=1.0000),平均回收率为100.15%,RSD为0.65%。结论本方法专属强、准确度高,可用于阿齐沙坦片的含量测定。 Objective To establish an HPLC method for the determination of Azilsartan Tablets. Methods A stable HPLC method was established, and the chromatography was accomplished on an Welch Ultimate XB C18 column (150 mm× 4.6 mm, 5 μm), the mobile phase consisted of acetonitrile-pH 2.8 buffer (1.56 g of sodium dihydrogen phosphate and 0.87 g of sodium pentane sulfonate were dissolved in 1000 ml of water, and the pH was adjusted to 2.8 with phosphoric acid) (45:55), the detection wavelength was 251 nm, and the flow rate was 1.0 ml/min. Results The calibration curve was linear in the range of 0.021-0.5232 mg/ml (r=1), the average recovery was 100.15 %, with corresponding RSD of 0.65 %. Conclusion This method has high specialty and accuracy, and can be used for the determination of Azilsartan Tablets.
作者 司海霞 SI Hai-xia(Lunan Pharmaceutical Group Co.,Ltd.,Linyi 276000,China)
出处 《食品与药品》 CAS 2018年第5期344-347,共4页 Food and Drug
关键词 阿齐沙坦片 高效液相色谱法 含量测定 Azilsartan Tablets HPLC determination
  • 相关文献

参考文献4

二级参考文献43

  • 1李萍,王彤,刘玉超.常用抗高血压药的分类及应用[J].军医进修学院学报,2006,27(1):79-80. 被引量:6
  • 2吕卓人,黄若文,薛小临.2005年高血压领域中的热点问题[J].中国医刊,2006,41(8):5-7. 被引量:16
  • 3尹桂华.抗高血压药物的分类与合理使用[J].中国热带医学,2007,7(8):1400-1401. 被引量:11
  • 4FDA. Guidance for Industry: Analytical procedures and methods validation, chemistry, manufacturing, and controls documentation (Draft) [S]. 2000.
  • 5ICH Q2A :Test on Validation of Analytical Procedures[S]. 2007.
  • 6ICH Q2B : Validation of Analytical Procedures : Methodology [ S ]. 2007.
  • 7FDA. Pharmacology review [ EB/OL]. [2011 - 04 - 04 ]. http://www, accessdata, fda. gov/scripts/cder/drugsatfda/index. cfm? fuseaction = Search. Label ApprovaiHistory.
  • 8FDA. Clinical pharmacology biopharmaceutics review[ EB/OL]. FDA. [2011 -04 -04]. http://www, accessdata, fda. gov/ scripts/cder/drugsatfda/index, cfm? fuseaction = Search. Label_.
  • 9FDA. Medical review [ EB/OL1. [ 2011 - 04 - 04 ]. http://: www. aceessdata, fda. gov/seripts/cder/drugsatfda/index, cfm? fuseaction = Search. Label_.
  • 10Bill Berkrot. Takeda blood pressure drug tops rivals in studies [ EB/OL ]. [ 2010 - 05 - 03 ]. http ://www. reuters, com/article/ 2010/05/03/hypertension-takeda-idUSN0220734220100503.

共引文献28

同被引文献27

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部